BioWorld

May 19, 2003

Roche Pays Isotechnika $16M As Psoriasis Drug Advances

Isotechnika Inc. lined its coffers courtesy of a C$21.9 million (US$16 million) milestone payment following an achievement in the development of its lead product. (BioWorld Today) Read More

New Drugs Unlikely To Topple Viagra For ED: Physician Survey

Ariad's Run Of Good News Highlighted By Court Ruling

House Committee's BioShield Version Unfriendly To Industry

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 4, 2025.

Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B

BioWorld

Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1...

Pharma execs speak out: UK pricing rebates scare investors

BioWorld

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...

ASCO 2025: Verastem has positive cancer data but stock sags

BioWorld

New dose-escalation data from Verastem Oncology’s phase I/II cancer study in China prompted the company to say it was encouraged by the efficacy results. However,...